Skip to main content
. 2019 Jul 9;10(5):1595–1622. doi: 10.1007/s13300-019-0657-8

Fig. 6.

Fig. 6

ADA/EASD consensus on treatment selection in T2DM when considering CVD or renal outcomes.

Adapted with permission from [101]